SCCOMBKU Researchers Awarded Grant for Clinical Trial

TMB-MBKU-CITT-ART-study-team
Members of the MBKU study team, left to right in the front row, are Dr. Kristine Huang, Dr. Raymond Chu and Dr. Carmen Barnhardt, and left to right in the back row, Dr. Susan Cotter, Dr. Eric Borsting and Sue Parker. Not pictured is Dr. Angela Chen.

Members of the MBKU study team, left to right in the front row, are Dr. Kristine Huang, Dr. Raymond Chu and Dr. Carmen Barnhardt, and left to right in the back row, Dr. Susan Cotter, Dr. Eric Borsting and Sue Parker. Not pictured is Dr. Angela Chen.

Researchers at Marshall B. Ketchum University (MBKU) have received a $665,500 grant from the National Institutes of Health/National Eye Institute to study the relationship between a common childhood vision condition, convergence insufficiency, and reading performance. The grant will fund the Convergence Insufficiency Treatment Trial – Attention and Reading Trial (CITT-ART), a national multicenter clinical trial that involves optometry, ophthalmology, psychiatry and education in evaluating how this eye-teaming problem affects a child’s attention and reading performance.

MBKU is one of eight locations in the United States participating in the clinical trial. Enrollment is expected to begin this fall.